Cognizant price target raised to $82 from $80 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Cognizant (CTSH) to $82 from $80 and keeps an Equal Weight rating on the shares. With large deal ramps across Financial Services and Health Sciences, the firm thinks Cognizant is benefitting from vendor consolidation and argues that operating margin expansion “remains compelling.”